The Impact of PIVKA-II as a Predictor of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
PIVKA-II is a highly specific tumor marker for hepatocellular carcinoma (HCC) and is used to detect HCCearly in cirrhosis patients and to assess response to therapy and prognosis in HCC patients. The usefulness ofPIVKA-II in liver transplant recipients with end-stage cirrhosis or with HCC has yet to...
Saved in:
Published in | Nippon Shokaki Geka Gakkai zasshi Vol. 40; no. 9; pp. 1549 - 1556 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Japanese |
Published |
The Japanese Society of Gastroenterological Surgery
2007
|
Subjects | |
Online Access | Get full text |
ISSN | 0386-9768 1348-9372 1348-9372 |
DOI | 10.5833/jjgs.40.1549 |
Cover
Abstract | PIVKA-II is a highly specific tumor marker for hepatocellular carcinoma (HCC) and is used to detect HCCearly in cirrhosis patients and to assess response to therapy and prognosis in HCC patients. The usefulness ofPIVKA-II in liver transplant recipients with end-stage cirrhosis or with HCC has yet to be clarified. Materialsand Methods: Subjects were 24 cirrhosis patients without HCC and 123 HCC patients undergoing liver transplantation between 1999 and 2005. Subjects were examined for the PIVKA-II distribution and its correlationwith histopathological findings of HCC and prognosis. Results: We found 58% of cirrhosis patients withoutHCC were positive for PIVKA-II. The mean Child-Pugh and MELD scores in the PIVKA-II positive group (10.8 and 20.9 points) were significantly higher than in the negative group (p<0.05). Of patients with HCC, cumulative recurrence at 5 years was significantly higher in the group with PIVKA-II≤400mAU/ml than inthose with PIVKA-II≤400mAU/ml (60% vs. 13%, p<0.01). Multivariate analysis showed that PIVKA-II exceeding 400mAU/ml was an independent predisposing factor for HCC recurrence (risk ratio, 5.984; p<0.01).Median PIVKA-II in patients with positive microscopic portal venous invasion was significantly higher thanthat in negative patients (p<0.01). Conclusions: High positive ratio of PIVKA-II in patients with cirrhosismay be due to severe liver damage. PIVKA-II is thus a highly useful tumor marker as a predisposing factorfor HCC recurrence of after liver transplantation, which is closely correlated with histopathological features ofHCC. |
---|---|
AbstractList | PIVKA-II is a highly specific tumor marker for hepatocellular carcinoma (HCC) and is used to detect HCCearly in cirrhosis patients and to assess response to therapy and prognosis in HCC patients. The usefulness ofPIVKA-II in liver transplant recipients with end-stage cirrhosis or with HCC has yet to be clarified. Materialsand Methods: Subjects were 24 cirrhosis patients without HCC and 123 HCC patients undergoing liver transplantation between 1999 and 2005. Subjects were examined for the PIVKA-II distribution and its correlationwith histopathological findings of HCC and prognosis. Results: We found 58% of cirrhosis patients withoutHCC were positive for PIVKA-II. The mean Child-Pugh and MELD scores in the PIVKA-II positive group (10.8 and 20.9 points) were significantly higher than in the negative group (p<0.05). Of patients with HCC, cumulative recurrence at 5 years was significantly higher in the group with PIVKA-II≤400mAU/ml than inthose with PIVKA-II≤400mAU/ml (60% vs. 13%, p<0.01). Multivariate analysis showed that PIVKA-II exceeding 400mAU/ml was an independent predisposing factor for HCC recurrence (risk ratio, 5.984; p<0.01).Median PIVKA-II in patients with positive microscopic portal venous invasion was significantly higher thanthat in negative patients (p<0.01). Conclusions: High positive ratio of PIVKA-II in patients with cirrhosismay be due to severe liver damage. PIVKA-II is thus a highly useful tumor marker as a predisposing factorfor HCC recurrence of after liver transplantation, which is closely correlated with histopathological features ofHCC. |
Author | Takada, Yasutsugu Ito, Takashi Uemoto, Shinji Fujiki, Masato |
Author_xml | – sequence: 1 fullname: Uemoto, Shinji organization: Department of Gastrointestinal Surgery, Kyoto University – sequence: 1 fullname: Ito, Takashi organization: Department of Gastrointestinal Surgery, Kyoto University – sequence: 1 fullname: Takada, Yasutsugu organization: Department of Gastrointestinal Surgery, Kyoto University – sequence: 1 fullname: Fujiki, Masato organization: Department of Gastrointestinal Surgery, Kyoto University |
BookMark | eNqFkN1KxDAQhYMouOre-QB5ALs2TZuml7L4U1xQZPW2TNOJZs2mJckqvr3Wlb0QxJv54XxnBs4R2Xe9Q0JOWTorJOfnq9VzmOXpjBV5tUcmjOcyqXiZ7ZNJyqVIqlLIQzINwbRpWsjya2cT8rp8QVqvB1CR9pre10-3F0ldUwgU6L3HzqjY-1G6wQFir9DajQVP5-CVcf0a6AOqjffoFFLj6MK8oadLDy4MFlwcZTMYdDGckAMNNuD0px-Tx6vL5fwmWdxd1_OLRaJ4WlaJqHLZZoXoBCLXBbRdm3UdayVWCnMQ0GVC81bIQiDTknV5Nw6codZZqTN-TJLt3Y0b4OMdrG0Gb9bgPxqWNmNYzRhWk6fNGNYXn2155fsQPOpGmQjR9C56MPYv09kv0z8_Lrf4KkR4xh0MPhpl8RtmlahGw08ZfTtdvYBv0PFPtauZOA |
CitedBy_id | crossref_primary_10_2957_kanzo_60_39 |
ContentType | Journal Article |
Copyright | The Japanese Society of Gastroenterological Surg |
Copyright_xml | – notice: The Japanese Society of Gastroenterological Surg |
DBID | AAYXX CITATION ADTOC UNPAY |
DOI | 10.5833/jjgs.40.1549 |
DatabaseName | CrossRef Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1348-9372 |
EndPage | 1556 |
ExternalDocumentID | 10.5833/jjgs.40.1549 10_5833_jjgs_40_1549 article_jjgs1969_40_9_40_9_1549_article_char_en |
GroupedDBID | 2WC ALMA_UNASSIGNED_HOLDINGS EBS EJD JSF KQ8 OK1 RJT AAYXX CITATION ADTOC UNPAY |
ID | FETCH-LOGICAL-c3079-6948b256d6ee3f5abdb2dd1b8e9ce4a6ad26f3b6856e1f81d4d6e1f31eff27f23 |
IEDL.DBID | UNPAY |
ISSN | 0386-9768 1348-9372 |
IngestDate | Wed Oct 01 15:32:32 EDT 2025 Thu Apr 24 22:53:16 EDT 2025 Tue Jul 01 02:47:05 EDT 2025 Wed Sep 03 06:15:34 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 9 |
Language | Japanese |
License | https://creativecommons.org/licenses/by-nc/4.0/deed.ja cc-by-nc |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3079-6948b256d6ee3f5abdb2dd1b8e9ce4a6ad26f3b6856e1f81d4d6e1f31eff27f23 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.jstage.jst.go.jp/article/jjgs1969/40/9/40_9_1549/_pdf |
PageCount | 8 |
ParticipantIDs | unpaywall_primary_10_5833_jjgs_40_1549 crossref_citationtrail_10_5833_jjgs_40_1549 crossref_primary_10_5833_jjgs_40_1549 jstage_primary_article_jjgs1969_40_9_40_9_1549_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007 2007-00-00 |
PublicationDateYYYYMMDD | 2007-01-01 |
PublicationDate_xml | – year: 2007 text: 2007 |
PublicationDecade | 2000 |
PublicationTitle | Nippon Shokaki Geka Gakkai zasshi |
PublicationTitleAlternate | Jpn J Gastroenterol Surg |
PublicationYear | 2007 |
Publisher | The Japanese Society of Gastroenterological Surgery |
Publisher_xml | – name: The Japanese Society of Gastroenterological Surgery |
References | 7) Marsh JW, Dvorchik I, Bonham CA et al: Is the pathologic TNM staging system for patients with hepatoma predictive of outcome ? Cancer 88: 538-543, 2000 5) Wiesner R, Edwards E, Freeman R et al: Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124: 91-96, 2003 9) Kemmer N, Neff G, Kaiser T et al: An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma. Liver Transpl 12: 1519-1522, 2006 4) 崎園賢治, 老田達雄, 江藤正明ほか: アルコール性肝硬変における血中PIVKA-II上昇の起因の解明. 臨病理50: 289-295, 2002 10) Shimada M, Yonemura Y, Ijichi H et al: Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value. Transplant Proc 37: 1177-1179, 2005 6) Takada Y, Ueda M, Ito T et al: Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl 12: 912-919, 2006 11) Hamamura K, Shiratori Y, Shiina S et al: Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein. Cancer 88: 1557-1564, 2000 2) 久保定徳, 松川正明: 肝細胞癌の腫瘍マーカー. 癌と化療31: 2203-2206, 2004 1) Liebman H, Furie BC, Tong MJ et al: Desgamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310: 1427-1431, 1984 8) Yao FY, Ferrell L, Bass NM et al: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394-1403, 2001 3) 松枝由美, 米澤久子: IRMAを用いたPIVKA-II測定キットの基礎的ならびに臨床的検討. 核医技19: 338-345, 2000 12) Koike Y, Shiratori Y, Sato S et al: Des-gammacarboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 91: 561-569, 2001 |
References_xml | – reference: 4) 崎園賢治, 老田達雄, 江藤正明ほか: アルコール性肝硬変における血中PIVKA-II上昇の起因の解明. 臨病理50: 289-295, 2002 – reference: 12) Koike Y, Shiratori Y, Sato S et al: Des-gammacarboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 91: 561-569, 2001 – reference: 1) Liebman H, Furie BC, Tong MJ et al: Desgamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310: 1427-1431, 1984 – reference: 2) 久保定徳, 松川正明: 肝細胞癌の腫瘍マーカー. 癌と化療31: 2203-2206, 2004 – reference: 6) Takada Y, Ueda M, Ito T et al: Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl 12: 912-919, 2006 – reference: 3) 松枝由美, 米澤久子: IRMAを用いたPIVKA-II測定キットの基礎的ならびに臨床的検討. 核医技19: 338-345, 2000 – reference: 8) Yao FY, Ferrell L, Bass NM et al: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394-1403, 2001 – reference: 10) Shimada M, Yonemura Y, Ijichi H et al: Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value. Transplant Proc 37: 1177-1179, 2005 – reference: 5) Wiesner R, Edwards E, Freeman R et al: Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124: 91-96, 2003 – reference: 9) Kemmer N, Neff G, Kaiser T et al: An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma. Liver Transpl 12: 1519-1522, 2006 – reference: 11) Hamamura K, Shiratori Y, Shiina S et al: Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein. Cancer 88: 1557-1564, 2000 – reference: 7) Marsh JW, Dvorchik I, Bonham CA et al: Is the pathologic TNM staging system for patients with hepatoma predictive of outcome ? Cancer 88: 538-543, 2000 |
SSID | ssib005879761 ssib000936942 ssib023160767 ssib058493923 ssj0000491391 ssib002223853 |
Score | 1.6376708 |
Snippet | PIVKA-II is a highly specific tumor marker for hepatocellular carcinoma (HCC) and is used to detect HCCearly in cirrhosis patients and to assess response to... |
SourceID | unpaywall crossref jstage |
SourceType | Open Access Repository Enrichment Source Index Database Publisher |
StartPage | 1549 |
SubjectTerms | cirrhosis DCP hepatocellular carcinoma liver transplantation PIVKA-II |
Title | The Impact of PIVKA-II as a Predictor of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients |
URI | https://www.jstage.jst.go.jp/article/jjgs1969/40/9/40_9_1549/_article/-char/en https://www.jstage.jst.go.jp/article/jjgs1969/40/9/40_9_1549/_pdf |
UnpaywallVersion | publishedVersion |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | The Japanese Journal of Gastroenterological Surgery, 2007, Vol.40(9), pp.1549-1556 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1348-9372 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000491391 issn: 0386-9768 databaseCode: KQ8 dateStart: 19690101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Rb9MwED6xDmnaAzDBtCKo_AC8TEkW23WTF6SqYmoZTN20Iniy7Niu2pUkWlsh-PX4kjRiSCAkXpJIPiXOfU7u7Lv7DPCKxhnSrvUDLTIecEFdoJDwUus0swkzTGkscP54KcYz_v5zf5dNuG7SKpfeL5pbPIXzIlyWUaPEaLmcr5HOJeJnER5kKpFhLJKlcXuwLzDG1IH92eV0-KWKHiQi8Oa2Kodj3H_YbEDr5HesNapuF_JqcSW9Z5Ye1j04hINtXqrv39Rq9YvROX8MetfdOtfkNtxudJj9-I3J8b_e5wk8alxSMqzFj-CBzZ_CrR8_ZFKVUJLCkenk08UwmEyIWhNFpncY3vGzdWwae4O2KTAAgBmtZISbE-XFV0WucSm_KiYki5x8wAQQUnOprzyc2LwosRpz_Qxm5-9uRuOg2ZghyPwvIQ1EyhPtfSUjrGWur7TR1JhYJ9YDzJVQhgrHtEj6wsbOe8Tc4AWLrXN04Cg7hk5e5PYEyEBzZ6gTsY4VF8z7r0pnZ1abjCeOikEXTne4yKxhLcfNM1bSz14QRYlKlF53qLkuvG6ly5qt4w9yb2tQWqkGErmDRFZotJC07VgL538oXXjTDo2_Pun5vwq-gM7mbmtfehdno3uwd3GV9Jqh_BN0ev-P |
linkProvider | Unpaywall |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swEBddOhh92Fa20ZR16GHdy7BdS7JivxRCWEjWLoSylPZJSJYUmqa2yQdj_eur8xdroWOwF9ugw5bvJ_tOurufEPpMwhRo1yJP8ZR5jBPrSSC8VCpJTUw1lQoKnH9M-GjGvl9FTTbhuk6rXDi_aG7g5M9zf1EEtRKDxWK-BjqXgJ0EcBCJAIaxQBTavkC7HGJMHbQ7m0z712X0IOaeM7dlORxl7sOmPVIlv0OtUXk7n5WLK8kjs_Sy6sEeerXNCvn7l1wu_zA6wzdINd2tck1u_e1G-en9EybH_3qft-h17ZLifiW-j3ZM9g7duvGDx2UJJc4tno4vz_reeIzlGks8XUF4x83WoWnkDNomhwAAZLTiAWxOlOV3El_AUn5ZTIhvMnwOCSC44lJfOjih-aaAasz1ezQbfvs5GHn1xgxe6n4JiccTFivnK2luDLWRVFoRrUMVGwcwk1xqwi1VPI64Ca3ziJmGCxoaa0nPEvoBdbI8MwcI9xSzmlgeqlAyTp3_KlV6YpROWWwJ73XR1wYXkdas5bB5xlK42QugKECJwukONNdFx610UbF1PCN3WoHSStWQiAYSUaLRQtK2Qy2c-6F00Zd2aPz1SYf_KvgRdTarrTlyLs5GfaoH8QN8gf6a |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+PIVKA-II+as+a+Predictor+of+Hepatocellular+Carcinoma+Recurrence+in+Liver+Transplant+Recipients&rft.jtitle=The+Japanese+Journal+of+Gastroenterological+Surgery&rft.au=Uemoto%2C+Shinji&rft.au=Ito%2C+Takashi&rft.au=Takada%2C+Yasutsugu&rft.au=Fujiki%2C+Masato&rft.date=2007&rft.pub=The+Japanese+Society+of+Gastroenterological+Surgery&rft.issn=0386-9768&rft.eissn=1348-9372&rft.volume=40&rft.issue=9&rft.spage=1549&rft.epage=1556&rft_id=info:doi/10.5833%2Fjjgs.40.1549&rft.externalDocID=article_jjgs1969_40_9_40_9_1549_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0386-9768&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0386-9768&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0386-9768&client=summon |